ArticleNeurogastroenterology and motility2026
Postbiotic Stool Filtrates From Patients With Type 2 Diabetes Impair Mouse Intestinal Muscle Contractility Ex Vivo and Alter Enteric Cholinergic Neuronal Activity in Vivo.
Article in Neurogastroenterology and motility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundType 2 diabetes (T2D) is associated with gastrointestinal dysfunction, enteric nervous system damage, and microbiome dysbiosis. We aimed to investigate whether filter-sterilized postbiotic stool filtrates (PSFs) from patients with prediabetes (PD) and T2D inhibit muscle contractions ex vivo, and whether T2D PSFs impair cholinergic enteric neurons in vivo.
methodsDuodenojejunal muscularis from healthy mice were cultured with PSFs from patients with PD, T2D, or healthy subjects. Mouse PSFs served as control. PSFs of T2D patients or healthy subjects were intragastrically gavaged into healthy mice expressing GCaMP6f in cholinergic neurons. Stomachs and distal colons were used to assess cholinergic myenteric neuron activity via Ca KEY
resultsPrediabetes and T2D PSFs inhibited contractions and dissociated cells from duodenojejunal muscularis. These effects were reversed by endotoxin-binding filters and reduced by a protease inhibitor cocktail and heating. PSFs from T2D patients decreased gastrointestinal motility and increased the amplitude of Ca CONCLUSIONS AND INFERENCES: These findings suggest that unidentified proteases and other molecules in the PSFs of PD and T2D patients contribute to gastrointestinal dysmotility by inhibiting muscle contractility and inducing cholinergic neuronal hyperactivity. PSFs from healthy male subjects contain neurotrophic factors that are reduced in T2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.